Celldex Therapeutics, Inc.
NASDAQ:CLDX
26.22 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.883 | 2.357 | 4.651 | 7.418 | 3.573 | 9.538 | 12.743 | 6.786 | 5.48 | 3.586 | 4.111 | 11.202 | 9.265 | 46.793 | 15.18 | 7.456 | 5.103 | 4.931 | 3.088 | 6.859 | 4.633 | 6.705 | 3.346 | 0.763 | 1.484 | 2.2 | 1.2 | 1.1 | 4 | 7 | 9 | 6.6 | 10.2 | 10.9 | 7.8 | 4.6 | 2.2 | 0.1 |
| Cost of Revenue
| 3.008 | 1.4 | 3.068 | 42.534 | 42.672 | 66.449 | 96.171 | 102.026 | 4.011 | 101.881 | 2.334 | 10.775 | 9.119 | 12.077 | 8.397 | 0 | 0 | 0 | 0 | 0 | 0 | 0.041 | 0.037 | -0.689 | -0.713 | -0.4 | -0.3 | -0.1 | 1.2 | 1.2 | 1.5 | 0.6 | 1.1 | 0.8 | 0.8 | 0.3 | -0.1 | 0 |
| Gross Profit
| 3.875 | 0.957 | 1.583 | -35.116 | -39.099 | -56.911 | -83.428 | -95.24 | 1.469 | -98.295 | 1.777 | 0.427 | 0.146 | 34.716 | 6.783 | 7.456 | 5.103 | 4.931 | 3.088 | 6.859 | 4.633 | 6.664 | 3.309 | 1.453 | 2.196 | 2.6 | 1.5 | 1.2 | 2.8 | 5.8 | 7.5 | 6 | 9.1 | 10.1 | 7 | 4.3 | 2.3 | 0.1 |
| Gross Profit Ratio
| 0.563 | 0.406 | 0.34 | -4.734 | -10.943 | -5.967 | -6.547 | -14.035 | 0.268 | -27.411 | 0.432 | 0.038 | 0.016 | 0.742 | 0.447 | 1 | 1 | 1 | 1 | 1 | 1 | 0.994 | 0.989 | 1.903 | 1.48 | 1.182 | 1.25 | 1.091 | 0.7 | 0.829 | 0.833 | 0.909 | 0.892 | 0.927 | 0.897 | 0.935 | 1.045 | 1 |
| Reseach & Development Expenses
| 115.003 | 82.258 | 53.311 | 42.534 | 42.672 | 66.449 | 96.171 | 102.726 | 100.171 | 104.381 | 67.401 | 47.398 | 32.439 | 27.65 | 26.169 | 26.347 | 18.496 | 18.066 | 14.063 | 13.874 | 10.021 | 14.709 | 21.581 | 10.774 | 7.872 | 5.7 | 5.3 | 6 | 8 | 8.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 30.914 | 27.195 | 20.488 | 14.456 | 15.426 | 19.269 | 25.003 | 35.979 | 33.837 | 20.622 | 14.805 | 10.016 | 9.243 | 10.428 | 17.119 | 14,747.392 | 8,501.891 | 0 | 6,894.951 | 0 | 0 | 0 | 4.914 | 4.808 | 4.28 | 3.8 | 3.5 | 6.5 | 5.9 | 5.8 | 16 | 0 | 12.9 | 11.5 | 8.3 | 6.1 | 3.7 | 1.9 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,732.645 | -8,493.389 | 0 | -6,888.056 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 30.914 | 27.195 | 20.488 | 14.456 | 15.426 | 19.269 | 25.003 | 35.979 | 33.837 | 20.622 | 14.805 | 10.016 | 9.243 | 10.428 | 17.119 | 14.747 | 8.502 | 8.237 | 6.895 | 5.572 | 5.351 | 5.592 | 4.914 | 4.808 | 4.28 | 3.8 | 3.5 | 6.5 | 5.9 | 5.8 | 16 | 10.1 | 12.9 | 11.5 | 8.3 | 6.1 | 3.7 | 1.9 |
| Other Expenses
| 130.233 | 90.34 | 55.375 | 54.015 | 42.705 | 0.224 | 0.896 | 0.997 | 1.013 | 1.013 | 1.013 | 1.09 | 1.913 | 3.143 | 0.345 | 0.361 | 0.96 | 0.995 | 0.995 | 0.995 | 0.995 | 0.795 | 1.376 | 1.311 | 1.989 | 1 | 0.4 | 0.5 | 0.7 | 0.8 | 0.9 | 0.6 | 0.6 | 0.5 | 0.3 | 0.2 | 0.2 | 0.1 |
| Operating Expenses
| 145.917 | 109.453 | 73.799 | 56.99 | 58.098 | 85.942 | 122.07 | 139.702 | 135.021 | 126.016 | 83.219 | 58.504 | 43.595 | 41.171 | 43.633 | 41.456 | 27.958 | 27.298 | 21.953 | 20.441 | 16.367 | 21.096 | 27.871 | 16.893 | 14.141 | 10.5 | 9.2 | 13 | 14.6 | 15.3 | 16.9 | 10.7 | 13.5 | 12 | 8.6 | 6.3 | 3.9 | 2 |
| Operating Income
| -142.042 | -115.234 | -71.243 | -63.354 | -55.031 | -156.436 | -121.527 | -132.916 | -129.541 | -122.43 | -81.442 | -58.077 | -43.399 | -6.455 | -36.85 | -48.756 | -22.855 | -22.367 | -18.865 | -13.582 | -11.734 | -14.432 | -24.561 | -15.441 | -11.944 | -7.9 | -7.7 | -11.8 | -11.8 | -9.5 | -9.4 | -4.7 | -4.4 | -1.9 | -1.6 | -2 | -1.6 | -1.9 |
| Operating Income Ratio
| -20.637 | -48.89 | -15.318 | -8.541 | -15.402 | -16.401 | -9.537 | -19.587 | -23.639 | -34.141 | -19.811 | -5.185 | -4.684 | -0.138 | -2.428 | -6.54 | -4.479 | -4.536 | -6.108 | -1.98 | -2.533 | -2.152 | -7.341 | -20.232 | -8.051 | -3.591 | -6.417 | -10.727 | -2.95 | -1.357 | -1.044 | -0.712 | -0.431 | -0.174 | -0.205 | -0.435 | -0.727 | -19 |
| Total Other Income Expenses Net
| 0.613 | 2.909 | 0.505 | 2.407 | 4.153 | -75.545 | -7.986 | 4.386 | 2.344 | 4.35 | 0.819 | 0.53 | 0.446 | 5.259 | 0.248 | -13.5 | 1.096 | 2.113 | 0.768 | 0.379 | 0.24 | 0.603 | 1.808 | -6.534 | 0.635 | -43.8 | -5.5 | 1 | 3.6 | -2.1 | 1.2 | 0.8 | 0.9 | 0.8 | 0.7 | 0.8 | 0.9 | 0.1 |
| Income Before Tax
| -141.429 | -112.325 | -70.738 | -60.947 | -50.878 | -151.949 | -117.313 | -128.53 | -127.197 | -118.08 | -81.55 | -59.123 | -44.799 | -2.533 | -37.054 | -62.256 | -21.759 | -20.254 | -18.097 | -13.204 | -11.494 | -13.829 | -22.753 | -21.975 | -11.309 | -7.9 | -13.2 | -10.8 | -8.2 | -11.6 | -8.2 | -3.9 | -3.5 | -1.1 | -0.9 | -1.2 | -0.7 | -1.8 |
| Income Before Tax Ratio
| -20.548 | -47.656 | -15.209 | -8.216 | -14.24 | -15.931 | -9.206 | -18.94 | -23.211 | -32.928 | -19.837 | -5.278 | -4.835 | -0.054 | -2.441 | -8.35 | -4.264 | -4.107 | -5.86 | -1.925 | -2.481 | -2.063 | -6.8 | -28.793 | -7.623 | -3.591 | -11 | -9.818 | -2.05 | -1.657 | -0.911 | -0.591 | -0.343 | -0.101 | -0.115 | -0.261 | -0.318 | -18 |
| Income Tax Expense
| 2.84 | 10.458 | -0.227 | -1.167 | -0.506 | -0.765 | -24.282 | -8.772 | -2.344 | -4.35 | -0.819 | -0.53 | -0.446 | -5.309 | -0.529 | 27.001 | -0.12 | 0.12 | -1.537 | -0.757 | 0.696 | -1.205 | -3.617 | 13.068 | -1.27 | 87.7 | 10.9 | -2 | -7.1 | 4.2 | -2.8 | -1.9 | -1.9 | -1.7 | -1.2 | -1.6 | -1.7 | -0.3 |
| Net Income
| -141.429 | -122.783 | -70.511 | -59.78 | -50.372 | -151.184 | -93.031 | -128.53 | -127.197 | -118.08 | -81.55 | -59.123 | -44.799 | -2.533 | -36.525 | -47.501 | -21.639 | -20.374 | -18.097 | -13.204 | -12.67 | -13.829 | -22.753 | -21.975 | -11.309 | -51.8 | -13.1 | -10.8 | -8.3 | -11.6 | -7.8 | -3.6 | -3.4 | -1 | -1.1 | -1.2 | -0.8 | -1.7 |
| Net Income Ratio
| -20.548 | -52.093 | -15.16 | -8.059 | -14.098 | -15.851 | -7.301 | -18.94 | -23.211 | -32.928 | -19.837 | -5.278 | -4.835 | -0.054 | -2.406 | -6.371 | -4.24 | -4.132 | -5.86 | -1.925 | -2.735 | -2.063 | -6.8 | -28.793 | -7.623 | -23.545 | -10.917 | -9.818 | -2.075 | -1.657 | -0.867 | -0.545 | -0.333 | -0.092 | -0.141 | -0.261 | -0.364 | -17 |
| EPS
| -2.92 | -2.62 | -1.64 | -2.02 | -3.47 | -14.48 | -10.86 | -18.99 | -19.66 | -19.81 | -15.33 | -15.37 | -17.01 | -1.19 | -27.64 | -50.12 | -468.75 | -49.41 | -43.93 | -32.57 | -36.48 | -41.17 | -70.63 | -75.43 | -46.18 | -281.04 | -89.06 | -89.61 | -85.46 | -122.55 | -82.48 | -48.26 | -57.95 | -18.89 | -23.8 | -26.22 | -17.49 | -37.21 |
| EPS Diluted
| -2.92 | -2.62 | -1.64 | -2.02 | -3.47 | -14.48 | -10.86 | -18.99 | -19.66 | -19.81 | -15.33 | -15.37 | -17.01 | -1.19 | -27.64 | -50.12 | -468.75 | -49.41 | -43.93 | -32.57 | -36.48 | -41.17 | -70.63 | -75.43 | -46.18 | -281.04 | -89.06 | -89.61 | -85.46 | -122.55 | -82.48 | -48.26 | -57.95 | -18.89 | -23.8 | -26.22 | -17.49 | -37.21 |
| EBITDA
| -139.034 | -101.867 | -67.558 | -38.197 | -58.172 | -0.635 | -96.031 | -136.305 | -130.872 | -121.417 | -78.497 | -56.987 | -41.982 | -3.312 | -33.318 | -17.962 | -21.264 | -22.385 | -17.504 | -12.245 | -10.447 | -13.413 | -24.113 | -7.596 | -10.591 | 36.9 | -1.8 | -12.3 | -14.7 | -6.6 | -9.7 | -4.9 | -4.7 | -2.2 | -2 | -2.6 | -2.3 | -1.9 |
| EBITDA Ratio
| -20.2 | -43.219 | -14.525 | -5.149 | -16.281 | -0.067 | -7.536 | -20.086 | -23.882 | -33.859 | -19.094 | -5.087 | -4.531 | -0.071 | -2.195 | -2.409 | -4.167 | -4.54 | -5.668 | -1.785 | -2.255 | -2 | -7.207 | -9.953 | -7.139 | 16.773 | -1.5 | -11.182 | -3.675 | -0.943 | -1.078 | -0.742 | -0.461 | -0.202 | -0.256 | -0.565 | -1.045 | -19 |